ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study
Our findings demonstrate a significant association between low plasma APOM levels and an increased risk of MACE in patients with CKD. These results suggest that APOM may play a role in cardiovascular protection in this vulnerable population.
Authors
- Gunnar H. Heine (ORCID: https://orcid.org/0000-0001-8320-5260)
- Julia T. Stadler (ORCID: https://orcid.org/0000-0003-1156-631X)
- Line S. Bisgaard (ORCID: https://orcid.org/0000-0001-6077-4487)
- Insa E. Emrich (ORCID: https://orcid.org/0000-0002-5048-3659)
- Susanne Bro (ORCID: https://orcid.org/0000-0003-3002-4188)
- Andrea Borenich (ORCID: https://orcid.org/0000-0002-2966-253X)
- Ditte Hansen (ORCID: https://orcid.org/0000-0003-4929-7901)
- Gunther Marsche (ORCID: https://orcid.org/0000-0002-2422-5381)
- Sasha Saurbrey Bjergfelt (ORCID: https://orcid.org/0000-0003-2769-4201)
- Christina Christoffersen (ORCID: https://orcid.org/0000-0003-3751-5203)
- Srinivasan Vijayakumar (ORCID: https://orcid.org/0000-0002-1678-9451)
- Line Melholt
Institutions
- University of Copenhagen (DK)
- Statistics Austria (AT)
- University of Graz (AT)
- Medical University of Graz (AT)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Research Center Pharmaceutical Engineering (Austria) (AT)
- Agaplesion Markus Hospital (DE)
- Saarland University (DE)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1161/atvbaha.124.322367
- Citations
- 2
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 2.79